4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one

C83H104F2N24O35 — CID 160712724

About 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one

4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one (PubChem CID 160712724) has the molecular formula C83H104F2N24O35 and a molecular weight of 2035.87 g/mol. Its IUPAC name is 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one.

Molecular Properties

• Compound Name: 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one
• PubChem CID: 160712724
• Molecular Formula: C83H104F2N24O35
• Molecular Weight: 2035.87 g/mol
• Exact Mass: 2034.71
• IUPAC Name: 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one
• SMILES: C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1c(C)cc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1cc(F)c(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1cnc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1ncc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1c(C)cc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1cc(F)c(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1ncc(N)nc1=O
• InChI: InChI=1S/2C13H17N3O5.2C12H14FN3O5.3C11H14N4O5/c2*1-4-13(20)10(18)9(7(3)17)21-11(13)16-6(2)5-8(14)15-12(16)19;2*1-3-12(20)8(18)7(5(2)17)21-10(12)16-4-6(13)9(14)15-11(16)19;1-3-11(19)7(17)6(5(2)16)20-8(11)15-4-13-9(12)14-10(15)18;2*1-3-11(19)8(17)7(5(2)16)20-9(11)15-10(18)14-6(12)4-13-15/h2*1,5,7,9-11,17-18,20H,2-3H3,(H2,14,15,19);2*1,4-5,7-8,10,17-18,20H,2H3,(H2,14,15,19);1,4-8,16-17,19H,2H3,(H2,12,14,18);2*1,4-5,7-9,16-17,19H,2H3,(H2,12,14,18)/t7-,9+,10-,11+,13?;7-,9-,10+,11-,13?;5-,7+,8-,10+,12?;5-,7-,8+,10-,12?;5-,6-,7+,8-,11?;5-,7+,8-,9+,11?;5-,7-,8+,9-,11?/m0101101/s1
• InChIKey: RSBNFKBBCXIHTK-CLRVMXQCSA-N
• XLogP: -16.12
• TPSA: 954.48 Ų
• H-Bond Donors: 28
• H-Bond Acceptors: 59
• Rotatable Bonds: 14
• Heavy Atoms: 144
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2035.87
LogP ≤ 5	-16.12
H-Bond Donors ≤ 5	28
H-Bond Acceptors ≤ 10	59

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one?

The IUPAC name of 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one (CID 160712724) is 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one.

What is the SMILES notation for 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one?

The canonical SMILES for 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one is C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1c(C)cc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1cc(F)c(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1cnc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@@H](C)O)O[C@H]1n1ncc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1c(C)cc(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1cc(F)c(N)nc1=O.C#CC1(O)[C@@H](O)[C@@H]([C@H](C)O)O[C@H]1n1ncc(N)nc1=O.

What is the InChIKey of 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one?

The InChIKey is RSBNFKBBCXIHTK-CLRVMXQCSA-N. The full InChI is InChI=1S/2C13H17N3O5.2C12H14FN3O5.3C11H14N4O5/c2*1-4-13(20)10(18)9(7(3)17)21-11(13)16-6(2)5-8(14)15-12(16)19;2*1-3-12(20)8(18)7(5(2)17)21-10(12)16-4-6(13)9(14)15-11(16)19;1-3-11(19)7(17)6(5(2)16)20-8(11)15-4-13-9(12)14-10(15)18;2*1-3-11(19)8(17)7(5(2)16)20-9(11)15-10(18)14-6(12)4-13-15/h2*1,5,7,9-11,17-18,20H,2-3H3,(H2,14,15,19);2*1,4-5,7-8,10,17-18,20H,2H3,(H2,14,15,19);1,4-8,16-17,19H,2H3,(H2,12,14,18);2*1,4-5,7-9,16-17,19H,2H3,(H2,12,14,18)/t7-,9+,10-,11+,13?;7-,9-,10+,11-,13?;5-,7+,8-,10+,12?;5-,7-,8+,10-,12?;5-,6-,7+,8-,11?;5-,7+,8-,9+,11?;5-,7-,8+,9-,11?/m0101101/s1.

What are the key properties of 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one?

4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one has a molecular weight of 2035.87 g/mol, XLogP of -16.12, 14 rotatable bonds, 28 hydrogen bond donors, and 59 hydrogen bond acceptors.

Where does this data come from?

All data for 4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-5-fluoropyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-6-methylpyrimidin-2-one;4-amino-1-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,3,5-triazin-2-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one;5-amino-2-[(2R,4S,5R)-3-ethynyl-3,4-dihydroxy-5-[(1S)-1-hydroxyethyl]oxolan-2-yl]-1,2,4-triazin-3-one is sourced from PubChem (CID 160712724), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).